Back to Trades
Jermasek Douglas
EVPCorporate StrategyCIK 0001955273
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Jermasek Douglas, EVP, Corporate Strategy, has filed 1 SEC report (2026), all concentrated in Unicycive Therapeutics, Inc. (UNCY), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jun 15 | UNCY Unicycive Therapeutics, Inc. | Jermasek Douglas | EVP, Corporate Strategy | Award | $0 |
1 filing